Cardiolipin IgG Antibody, in Visit Clinic

A positive cardiolipin IgG means you have anti‑cardiolipin antibodies (an antiphospholipid antibody). It can indicate antiphospholipid syndrome, which raises risk of blood clots and pregnancy complications, but may be transient after infection or medications. Diagnosis needs compatible clinical features, repeat testing at least 12 weeks later, and assessment of antibody titer. Discuss results with your clinician for further evaluation and management.

High anticardiolipin (cardiolipin) antibodies occur in antiphospholipid syndrome and other autoimmune disorders (especially systemic lupus erythematosus). They can appear transiently after infections (e.g., syphilis, hepatitis, HIV, some viral illnesses including COVID‑19), with certain medications, or in association with malignancies. Levels may be primary (idiopathic) or secondary and sometimes reflect temporary immune activation rather than chronic disease.

Cardiolipin abnormalities are linked to Barth syndrome (taffazin-related cardiomyopathy), antiphospholipid syndrome and systemic lupus erythematosus (cardiolipin autoantibodies causing thrombosis and pregnancy loss), mitochondrial dysfunction contributing to heart failure, ischemia–reperfusion injury, and neurodegenerative diseases (Parkinson’s, Alzheimer’s). Oxidized cardiolipin also appears in sepsis, aging, and may worsen metabolic disorders and chronic inflammation.

Anticardiolipin antibody results are reported in GPL (IgG) or MPL (IgM) units; exact cut-offs vary by lab. Commonly: <20 GPL/MPL is negative, 20–40 units is low/borderline, and >40 units is considered positive (moderate–high). Labs may use slightly different cut-offs; positive results should be repeated after ≥12 weeks for confirmation and clinical correlation.

Anti-cardiolipin antibodies can indicate antiphospholipid syndrome, increasing risk of blood clots and pregnancy loss. A single low‑titer positive often just needs repeat testing after 12 weeks and monitoring. Concern is greater with persistent high titres or a history of clotting or recurrent miscarriage. Discuss your results with your doctor—further testing and specialist referral determine if treatment or anticoagulation is needed.

Treatment depends on clinical context. Confirm positivity with repeat testing after 12 weeks. For thrombosis use therapeutic anticoagulation (heparin acutely, then warfarin—INR 2–3; higher or prolonged therapy for recurrent/arterial events). In pregnancy use low‑dose aspirin plus low‑molecular‑weight heparin. Stop estrogen, control cardiovascular risk factors, and consider specialist therapies (hydroxychloroquine or immunosuppression) for SLE or refractory cases.